• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Coave Sets Up SAB To Boost Genetic Medicines For Eye And CNS

    GLOBENEWSWIRE

    Coave`s ALIGATER™ Platform for Suprachoroidal Ocular Gene Delivery

    GLOBENEWSWIRE

    Coave Therapeutics to Present at Upcoming Conferences

    GLOBENEWSWIRE

    Coave appoints Leading World Experts to newly formed Scientific Advisory Board

    GLOBENEWSWIRE

    Coave Therapeutics to Present at Upcoming Conferences

    GLOBENEWSWIRE

    Coave Appoints Genetic Medicine Expert Lolita Petit, PhD as CSO

    GLOBENEWSWIRE

    Coave Therapeutics to Participate in Upcoming Conferences

    GLOBENEWSWIRE

    Coave Therapeutics Demonstrates its Modified coAAV Vectors Outperform AAV9

    GLOBENEWSWIRE

    Coave Therapeutics to Present at Upcoming Conferences

    GLOBENEWSWIRE

    Coave Therapeutics Strengthens Board of Directors

    PRNEWSWIRE

    Coave Therapeutics to Present at Cell and Gene Meeting on the Mesa

    PRNEWSWIRE

    Coave Therapeutics to Present at Chardan`s 6th Annual Genetic Medicines

    PRNEWSWIRE

    Coave to Collaborate with Institute of Neurodegenerative Diseases of Bordeaux

    PRNEWSWIRE

    Coave Appoints Catherine Mathis & Julien Berger in Leadership Team

    PRNEWSWIRE

    Coave Announces Formation of Scientific Advisory Board for Pipeline Strategy

    PRNEWSWIRE

    Coave Therapeutics and ABL Enter Gene Therapy Collaboration

    CONTRACTPHARMA

    Coave Therapeutics and ABL enter into strategic collaboration

    PRNEWSWIRE

    Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean

    PRNEWSWIRE

    Coave Therapeutics Appoints Thomas Blaettler as CMO and Patricia Françon as COO

    PRNEWSWIRE

    Théa pays for rights to Coave gene therapy in retinitis pigmentosa

    PRNEWSWIRE

    Coave and Théa sign agreement for Europe for CTx-PDE6b, in retinitis pigmentosa

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.